The therapy field for individuals with lung cancer has been changed due to Osimertinib (compound name remains the same), also referred to as Tagrisso (trade name remains the same).knowledge of the intricate details of this compound is paramount, given that its molecular structure is a key factor in its effectiveness.Osimertinib (compound name remains the same)'s molecular structure, characterized by its distinct arrangement of molecules, connections, and chemical groups, contributes to its capacity for targeting particular pathways in cancerous lung cells.In this section, the function of each functional group in Osimertinib…
